Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

COVID significantly increases risk of death from metastatic cancer, new study shows

Viruses like COVID-19 and the flu could awaken dormant cancer cells that have previously spread to the lungs, triggering growth of metastatic disease.

Largest U.S. pharmacist association has major concerns about government labeling it a biased special interest group

The American Pharmacists Association is being labeled as a biased special interest group under new rules for the CDC Advisory Committee on Immunization Practices, a move that seems to be politically motivated when APhA did not support changes in COVID vaccines earlier this year. 

cardiologist viewing heart data

Exploring the value of same-day permanent pacemaker implantation after TAVR

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker. 

doctorwithpatient.jpg

Early rhythm control boosts AFib outcomes for patients with obesity, diabetes

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

healthcare value value-based care money dollar

Salary update: Cardiologist compensation stays steady—thoracic surgeon pay takes a hit

Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties? 

MRI biomarkers predict cognitive impairment post-stroke

MRI biomarker could identify patients at risk of cognitive decline post-stroke

A new study’s findings highlight the potential for imaging biomarkers to help guide post-stroke care decisions in the future. 

ESC Congress 2022 European Society of Cardiology

The most anticipated trials at ESC 2025

The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.

Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.